Anaphylactic Reactions

Anaphylaxis protocols in emergency medical services have outdated recommendations and guidelines, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

DBV Technologies recently provided updates on its Viaskin Peanut Program for children and toddlers, announcing recruitment for the VITESSE study and progress in the COMFORT Toddlers supplemental safety study.

X4 Pharmaceuticals has announced that the FDA approved Xolremdi as a treatment for warts, hypogammaglobulinemia, infections and myelokathexis, also known as WHIM, syndrome, a rare and chronic primary immunodeficiency.

Patients experienced fewer reactions that required epinephrine during oral immunotherapy with peanut allergen powder compared with other immunotherapy methods, according to a study published in Annals of Allergy, Asthma & Immunology.

Zacky Muñoz is once again in front of the California state capitol with his third piece of legislation advocating to advance the safety of school-aged children with critical allergies.

ANAHEIM, Calif. — After diagnosing an IgE-mediated flaxseed allergy in an 18-month-old child, researchers recommended allergists be aware of this allergy as its incidence may increase with the growing popularity of flaxseed.

A panel of experts at the virtual American Academy of Allergy, Asthma and Immunology Annual Meeting highlighted current evidence on allergic reactions to available COVID-19 vaccines and how to assess patients who have had a reaction.